Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
February 2026
Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.
Read more
6
Mins
20 Jul 2023
EHA 2023 Abstract Highlights
Classical Hodgkin lymphoma, acute promyelocytic leukaemia, post-transplant relapse, massive transfusion, and many more essential topics in haematology were explored in several unique and insightful abstracts presented at the European Hematology Association (EHA) 2023 Congress.
19 Jul 2023
Chronic Lymphocytic Leukemia (CLL) and Beyond: Management of the Infection Burden
The overall survival of patients with chronic lymphocytic leukemia (CLL) has improved significantly over the years; however, the clinical…
12 Jul 2023
Evolving the treatment paradigm in cold agglutinin disease (CAD): Challenges and opportunities for optimal management
Prof. Alexander Röth (Chair), Prof. Wilma Barcellini, Prof. Josephine Vos and Prof. Bernd Jilma, will discuss about the evolving treatment paradigm in cold agglutinin disease (CAD): challenges and opportunities for optimal management.
11 Jul 2023
Sickle Cell Disease
This infographic gives informative statistics and explores the current prevalence of sickle cell disease globally, it also provides…
11 Jul 2023
What to do when CAR Ts are not the most appropriate option in 2L DLBCL: Current treatment options for transplant-ineligible patients
An innovative session highlighting patient-focused decision-making and a dynamic debate on current 2L DLBCL treatment options.
7 Jul 2023
Not All in Vein: Rare Haematology Disorders Explained
Morag Griffin joins Jonathan Sackier to discuss rare diseases in haematology and the impact of vaccinations on these conditions.
15 Jun 2023
Increased Risk of Acute Graft-Versus-Host Disease with Some Antibiotics
Some antibiotics are associated with a higher risk for acute graft-versus-host disease in the treatment of neutropenic fever. Read more…
15 Jun 2023
Are Pregnant Patients with Sickle Cell Disease at Higher Risk?
Pregnant patients with sickle cell disease have an increased risk of severe maternal morbidity, according to a recent cohort study…
Loading posts...
« Previous
1
…
53
54
55
56
57
…
100
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View